Selective Targeting of mHTT Presents Novel Therapeutic Approach to Huntington’s Disease
Engineered zinc finger protein transcription factors show promise in Huntington’s disease research by selectively repressing mutant HTT, affirms an article published by PerkingElmer last Thursday October, 7,
English 
Spanish 
Portuguese